Nanoparticles were formed by ternary complexing of DP, a targeted ligand-grafted lysine dendrimer peptide, and pDNA expressing shRNA for the bcl-2 gene, which targets the membrane ER (mER) in breast cancer cells. The gene discussed is ESR1; the disease is breast carcinoma.